Bayforest Capital Ltd Makes New Investment in Celsius Holdings Inc. (NASDAQ:CELH)

Key Points

• Bayforest Capital Ltd acquired a new position in Celsius Holdings Inc., purchasing 18,174 shares valued at approximately $647,000 in the first quarter.
• Analysts remain optimistic about Celsius, with multiple upgrades and price target increases, including a new target price of $52.00 from Roth Capital.
• Insider transactions included CEO John Fieldly selling over 130,000 shares and major shareholder William H. Milmoe selling 300,000 shares, reflecting notable insider activity.

Bayforest Capital Ltd bought a new position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 18,174 shares of the company's stock, valued at approximately $647,000.

Other large investors also recently added to or reduced their stakes in the company. Westside Investment Management Inc. acquired a new position in shares of Celsius in the first quarter valued at approximately $32,000. MassMutual Private Wealth & Trust FSB increased its stake in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after acquiring an additional 750 shares during the last quarter. UMB Bank n.a. lifted its stake in Celsius by 145.0% during the first quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock worth $51,000 after purchasing an additional 844 shares during the last quarter. Fifth Third Bancorp boosted its holdings in shares of Celsius by 62.9% in the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock valued at $61,000 after purchasing an additional 666 shares in the last quarter. Finally, Peterson Wealth Services acquired a new position in shares of Celsius during the 1st quarter worth $66,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CELH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lifted their target price on Celsius from $44.00 to $54.00 and gave the company an "overweight" rating in a research report on Thursday. Citigroup started coverage on shares of Celsius in a research note on Wednesday, July 23rd. They set a "buy" rating and a $55.00 target price on the stock. Roth Capital reiterated a "buy" rating and issued a $52.00 price target (up from $46.00) on shares of Celsius in a research note on Thursday, June 26th. Truist Financial raised their price objective on Celsius from $50.00 to $55.00 and gave the company a "buy" rating in a report on Monday, July 14th. Finally, Needham & Company LLC upped their target price on Celsius from $47.00 to $55.00 and gave the stock a "buy" rating in a report on Thursday, July 10th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Celsius presently has a consensus rating of "Moderate Buy" and a consensus price target of $47.83.

Celsius Stock Performance

NASDAQ CELH traded down $0.62 on Friday, hitting $44.72. The stock had a trading volume of 3,920,359 shares, compared to its average volume of 8,144,713. The firm has a 50-day moving average of $43.33 and a 200-day moving average of $35.27. The company has a market capitalization of $11.53 billion, a price-to-earnings ratio of 139.75, a price-to-earnings-growth ratio of 1.64 and a beta of 1.45. Celsius Holdings Inc. has a 52-week low of $21.10 and a 52-week high of $48.47.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a return on equity of 42.12% and a net margin of 8.40%. The business had revenue of $329.28 million for the quarter, compared to analysts' expectations of $349.09 million. During the same period in the previous year, the firm posted $0.27 EPS. The firm's revenue for the quarter was down 7.4% compared to the same quarter last year. As a group, research analysts anticipate that Celsius Holdings Inc. will post 0.89 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In related news, major shareholder Deborah Desantis sold 100,000 shares of the company's stock in a transaction on Monday, July 28th. The shares were sold at an average price of $47.00, for a total value of $4,700,000.00. Following the completion of the transaction, the insider directly owned 17,917,770 shares in the company, valued at approximately $842,135,190. The trade was a 0.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder William H. Milmoe sold 100,000 shares of the firm's stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $47.00, for a total value of $4,700,000.00. Following the sale, the insider owned 17,917,770 shares in the company, valued at $842,135,190. The trade was a 0.56% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 762,974 shares of company stock valued at $35,158,418. Insiders own 2.55% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.